For research use only. Not for therapeutic Use.
Ornidazole（Cat No.:A000985）is an antiprotozoal and antibacterial agent used primarily for the treatment of infections caused by anaerobic bacteria and protozoa. As a nitroimidazole derivative, Ornidazole exerts its action by disrupting DNA synthesis in microorganisms, leading to their death. It is commonly prescribed for treating conditions such as giardiasis, amoebiasis, and trichomoniasis, as well as for certain bacterial infections. Its high tissue penetration and relatively low toxicity make it a valuable option in clinical settings. Ornidazole is available in various formulations, including tablets and intravenous injections.
| Catalog Number | A000985 |
| CAS Number | 16773-42-5 |
| Synonyms | Ro7-0207, NSC 95075 |
| Molecular Formula | C7H10ClN3O3 |
| Purity | ≥95% |
| Target | Bacterial |
| Storage | 3 years -20C powder |
| IUPAC Name | 1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol |
| InChI | InChI=1S/C7H10ClN3O3/c1-5-9-3-7(11(13)14)10(5)4-6(12)2-8/h3,6,12H,2,4H2,1H3 |
| InChIKey | IPWKIXLWTCNBKN-UHFFFAOYSA-N |
| SMILES | CC1=NC=C(N1CC(CCl)O)[N+](=O)[O-] |
